45 episodes

Blood cancers are complex and multifaceted diseases, requiring knowledge by healthcare professionals on the array of diagnostic tests, treatment therapies, and survivorship issues. The LLS Podcast Series for Professionals provides up to date and accurate information on diagnosis, treatment and survivorship to educate HCPs treating patients with blood cancer. Listen in as we speak with experts who will guide us in understanding these topics, as well as address the importance of clinical trials, side effects management, and other concerns.

Treating Blood Cancers The Leukemia & Lymphoma Society

    • Science
    • 4.7 • 9 Ratings

Blood cancers are complex and multifaceted diseases, requiring knowledge by healthcare professionals on the array of diagnostic tests, treatment therapies, and survivorship issues. The LLS Podcast Series for Professionals provides up to date and accurate information on diagnosis, treatment and survivorship to educate HCPs treating patients with blood cancer. Listen in as we speak with experts who will guide us in understanding these topics, as well as address the importance of clinical trials, side effects management, and other concerns.

    Insights into Pediatric Survivorship for the HCP

    Insights into Pediatric Survivorship for the HCP

    Kevin C. Oeffinger, MD, FASCO, Duke University Medical Center, Durham, NC

























    Recorded on June 9, 2022











    Kevin C. Oeffinger, MD, FASCO

    Director, Duke Cancer Institute (DCI) Center for Onco-Primary Care

    Director, DCI Supportive Care and Survivorship Center

    Professor of Medicine, Division of Medical Oncology

    Department of Medicine

    Duke University Medical Center

    Durham, NC





    Children diagnosed with cancer are a heterogenous population experiencing different cancer diagnoses and therapies. Each journey presents its own physical, emotional, and psychosocial challenges that healthcare providers need to be attentive to. In this episode, Dr. Kevin Oeffinger, from Duke University in Durham, North Carolina, joins us to discuss the history of pediatric survivorship, physical, long-term, and late effects of treatment, including fertility considerations, strategies to support the survivor through psychosocial and cognitive effects, following a survivorship care plan, symptom monitoring, follow-up care, and so much more. Tune in to this important conversation today!











    This podcast episode is supported by Bristol Myers Squibb; Genentech, Inc. & Biogen; Pharmacyclics LLC, An AbbVie Company and Janssen Biotech, Inc.

    • 40 min
    PedAL: First-of-Its-Kind Global Master Clinical Trial for Pediatric Acute Leukemia

    PedAL: First-of-Its-Kind Global Master Clinical Trial for Pediatric Acute Leukemia

    Gwen L. Nichols, MD, The Leukemia & Lymphoma Society, Rye Brook, NY

























    Recorded on May 20, 2022







    Gwen L. Nichols, MD

    Chief Medical Officer

    The Leukemia & Lymphoma Society

    Rye Brook, NY









    Through the LLS Children’s Initiative, The Leukemia & Lymphoma Society (LLS) is setting out to fundamentally change how children with blood cancer are treated and cared for. For children and their families, LLS provides free education, support services, financial assistance, advocacy efforts, and has increased its research investments in childhood blood cancer. As part of this initiative, LLS PedAL, a first-of-its-kind global master clinical trial for pediatric acute leukemia patients, will fundamentally change how children are treated. In this episode, Dr. Gwen Nichols, EVP and Chief Medical Officer joins us to discuss PedAL, including sharing reflections on lack of pediatric ALL and AML therapies that led to the development of this master clinical trial. Dr. Nichols discusses challenges in creating pediatric therapies, the importance of data collection and creating a standard of care, and the ultimate impact PedAL will have on all clinical trials moving forward. Tune in today!

    • 41 min
    The Role of the Primary Care Physician in Treating Chronic Blood Cancers: Focus on Myeloma

    The Role of the Primary Care Physician in Treating Chronic Blood Cancers: Focus on Myeloma

    Zalman Suldan, MD, PhD, Hackensack University Medical Center – Hackensack Meridian Health, Hackensack, NJ

























    Recorded on May 3, 2022







    Zalman Suldan, MD, PhD

    Attending Physician

    Hackensack University Medical Center

    Hackensack Meridian Health

    Hackensack, NJ





    The primary care physician plays an important role in the treatment of patients living with a chronic blood disorder, from early diagnosis to appropriate referral to a hematologist-oncologist, from coordination of care to goals of therapy. In this episode, we are joined by Dr. Zalman Suldan, from Hackensack Medical Center in New Jersey, who shares his unique insights as both a primary care physician and nephrologist. Tune in today!











    This podcast episode is supported by Janssen Oncology, Pharmaceutical Companies of Johnson & Johnson.

    • 27 min
    CAR T-cell Therapy in 2022: What You Need to Know Part II

    CAR T-cell Therapy in 2022: What You Need to Know Part II

    Rayne H. Rouce, MD, BS, Texas Children’s Cancer Center for Cell and Gene Therapy, Houston, TX

























    Recorded on April 8, 2022







    Rayne H. Rouce, MD, BS

    Associate Professor

    Department of Pediatrics

    Texas Children’s Cancer Center for Cell and Gene Therapy

    Baylor College of Medicine

    Houston, TX





    As CAR T-cell therapy continues to evolve in new and exciting ways, new indications are approved and treatment toxicities reduced. In this episode, Dr. Rayne Rouce, from the Texas Children’s Cancer Center for Cell and Gene Therapy at Baylor College in Houston, joins us to discuss hot topics in CAR T-cell therapy, including how CAR-T has evolved over the past few years, understanding why some patients do better than others, access to treatment and overcoming logistics, shared care models with the referring physician, CAR-T in pediatric patients, communicating with patients, and so much more!











    This podcast episode is supported by Bristol Myers Squibb, CRISPR Therapeutics, Inc., Kite, a Gilead Company, Janssen Oncology & Legend Biotech, and Novartis Pharmaceuticals Corporation.

    • 38 min
    Everything You Need to Know About Cutaneous T-cell Lymphoma

    Everything You Need to Know About Cutaneous T-cell Lymphoma

    Francine Foss, MD and John A. Zic, MD, MMHC















    Recorded on March 28, 2022







    This informative episode covers everything you need to know about cutaneous T-cell lymphoma, from its biology, subclassifications, targeted therapy, goals of treatment, novel toxicities, and so much more! Join Dr. Ken Miller as he delves into cutaneous T-cell lymphoma with two special guests; Dr. Francine Foss from Yale University School of Medicine and Dr. John Zic from Vanderbilt University Medical Center. Learn more about cutaneous T-cell lymphoma from a 60,000 foot view, disparities in the delivery of care, and exciting new research presented at the United States Cutaneous Lymphoma Consortium Annual Meeting. Tune in today!













    Francine Foss, MD Professor of Medicine Section of Hematology and Stem Cell Transplantation Yale University School of MedicineNew Haven, CT











    John A. Zic, MD, MMHCProfessor of Dermatology Director, VU Cutaneous Lymphoma ClinicDepartment of DermatologyVanderbilt University Medical Center Nashville, TN

    • 43 min
    A Deep Dive into Myelofibrosis

    A Deep Dive into Myelofibrosis

    Srdan Verstovsek, MD, PhD, MD Anderson Cancer Center, Houston, TX

























    Recorded on February 18, 2022







    Srdan Verstovsek, MD, PhD

    Professor of Medicine

    Director, Hanns A. Pielenz Clinical Research Center

    for Myeloproliferative Neoplasms

    Department of Leukemia

    MD Anderson Cancer Center

    Houston, TX





    In this month’s episode, Dr. Srdan Verstovsek, from MD Anderson Cancer Center in Houston, Texas, joins us to discuss myelofibrosis. What is myelofibrosis? What is our understanding of the disease? What are the deciding factors for cells to branch off into myelofibrosis and not other myeloproliferative neoplasms? Tune in as we explore myelofibrosis, including discussion on diagnosing and staging, goals and considerations for therapy, the impact of COVID-19 on treatment, and new and emerging drugs in development.











    This podcast episode is supported by AbbVie Inc.

    • 38 min

Customer Reviews

4.7 out of 5
9 Ratings

9 Ratings

Ms.Vader ,

Lymphoma lesbian thanks you!

This was very comforting and informative. Wyoming isn’t the easiest place to get sensitive LGBTQI care. But we are doing ok so far. Blessings on your important work.

Top Podcasts In Science

Alie Ward
Hidden Brain
Jordan Harbinger
Vox
Sam Harris
PRX and Greater Good Science Center

You Might Also Like

Dr Neil Love
Vinay Prasad, MD MPH
American Society of Hematology
The New York Times
NPR
The New England Journal of Medicine